PamGene has a unique proprietary array-based platform to measure the activities of kinases & nuclear receptors, enabling deeper understanding of drug interactions with these important classes of signalling molecules. PamGene’s patented technology finds a wide range of applications including lead identification and optimization, (pre) clinical  translational research and biomarker development.

PamGene is an innovator in the field of personalized medicine. In summary, use of our technology and products aim to help to create better medicines and help to pre-select patients that actually have benefit from the medicne. In order to achieve this in practice we​ support:

  • research groups to discover new drug targets, optimise lead compounds and understand the mechanism of action of these compounds using cell line models.
  • toxicology groups with mechanistic tox studies and classical tox studies in an attempt to replace certain animal testing
  • translational biomarker groups in their goal to deliver leads and relevant PD and classification biomarkers to the clinic
  • patient classification for clinical trials.
Company website